CIK 0000939767
- Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043257395
- Phone
- +1 650-837-7000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-31 | Haley Patrick J. EVP, Commercial | Sale | −10,000 | $22.43 | $224K | 269,191 |
| 2022-03-31 | Haley Patrick J. EVP, Commercial | Option exercise · Option (right to buy) | −10,000 | 50,000 | ||
| 2022-03-29 | Hessekiel Jeffrey EVP, General Counsel & Sec | Sale | −13,283 | $22.00 | $292K | 605,236 |
| 2022-03-28 | Hessekiel Jeffrey EVP, General Counsel & Sec | Sale | −4,717 | $22.00 | $104K | 618,519 |
| 2022-03-04 | MORRISSEY MICHAEL President and CEO | Grant or award | +270,415 | 399,271 | ||
| 2022-03-04 | Senner Christopher J. EVP and CFO | Grant or award | +75,985 | 429,833 | ||
| 2022-03-04 | Hessekiel Jeffrey EVP, General Counsel & Sec | Grant or award | +67,875 | 623,236 | ||
| 2022-03-04 | Haley Patrick J. EVP, Commercial | Grant or award | +70,715 | 269,191 | ||
| 2022-03-04 | Lamb Peter EVP, Scientific Strategy & CSO | Grant or award | +59,490 | 402,485 | ||
| 2022-03-02 | MORRISSEY MICHAEL President and CEO | Gift | −50,000 | 1,196,316 | ||
| 2022-03-01 | Garber Alan M Director | Option exercise | +40,000 | $3.13 | $125K | 52,718 |
| 2022-03-01 | Garber Alan M Director | Sale | −21,301 | $21.00 | $447K | 31,417 |
| 2022-03-01 | Garber Alan M Director | Option exercise · Option (right to buy) | −40,000 | 0 | ||
| 2022-02-25 | Haley Patrick J. EVP, Commercial | Sale | −31,238 | $19.53 | $610K | 198,476 |
| 2022-02-24 | Hessekiel Jeffrey EVP and General Counsel | Sale | −18,000 | $20.00 | $360K | 555,361 |
| 2022-02-22 | PAPADOPOULOS STELIOS Director | Sale | −84,515 | $19.56 | $1.7M | 1,220,036 |
| 2022-02-22 | FELDBAUM CARL B Director | Option exercise | +20,000 | $3.13 | $63K | 28,521 |
| 2022-02-22 | FELDBAUM CARL B Director | Sale | −20,000 | $19.49 | $390K | 8,521 |
| 2022-02-22 | FELDBAUM CARL B Director | Option exercise · Option (right to buy) | −20,000 | 0 | ||
| 2022-02-15 | Lamb Peter EVP, Scientific Strategy & CSO | Shares withheld for taxes | −2,526 | $18.59 | $47K | 360,646 |
Page 26 of 29 · 580 trades